-
Blood: Daremu mono-anti-combined CyBorD therapy newly diagnosed AL amyloid
Time of Update: 2020-05-29
Although treatments for light-stranded (AL) amyloid have not yet been approved, cyclophosphamide, boratiandami and CyBorD are considered standard treatments for newly diagnosed patients Based on th
-
T-cell therapy DSG3-CAART fda edited fast-track: for the treatment of common mucosal blisters
Time of Update: 2020-05-29
Cabaletta is a clinical-stage biotechnology company dedicated to the development of T-cell therapies for autoimmune diseases The U.S Food and Drug Administration (FDA) has granted fast-track certif
-
Ann Rheum Dis: The Efficacy of Rheumatoid Arthritis Medication: 2019 Updated Guidelines for the Treatment of Rheumatoid Arthritis
Time of Update: 2020-05-29
The study aims to inform the European Union against Rheumatoid (EULAR) guidelines for the treatment of rheumatoid arthritis (RA) updated in 2019 conducted a systematic literature study (SLR) by r
-
J Rheumatol: High prevalence of lupus comorbidities in patients with psoriasis arthritis
Time of Update: 2020-05-29
The study was designed to assess the prevalence of lupus (SLE) in psoriasis arthritis (PsA) and to compare it with the general population using a database of large health care providers study ana
-
Lancet Rheumato: Effect of treatment within 6 weeks of rheumatic symptoms on prognosis
Time of Update: 2020-05-29
The first recommendation of the European Union against Rheumatology for early arthritis treatment is that patients should be treated by a professional rheumatologist within 6 weeks of the onset of
-
Lancet: secukinumab vs adalimumab for psoriasis arthritis
Time of Update: 2020-05-29
THE EXCEED STUDY COMPARED THE EFFICACY AND SAFETY OF PATIENTS WITH PSORIASIS ARTHRITIS AT 52 WEEKS IN A HEAD-TO-HEAD TRIAL INVOLVING PATIENTS WITH PSORIASIS ARTHRITIS studies were conducted in 1
-
J Rheumatol: The efficacy of continuous and intermittent ceresibu treatment of osteoarthritis
Time of Update: 2020-05-29
The purpose of this study was to determine whether "continuous" ceresib was more effective than "intermittent" in preventing knee and/or hip osteoarthritis (OA) flares a double-blind, randomized
-
Clin Exp Rheumatol: Midax spinal arthritis patients with cervical artery ultrasound reclassified as hyper-high-risk cardiovascular risk
Time of Update: 2020-05-29
Subclinical atherossclerosis, defined as the presence of cervical plaques, is more common in patients with midashaft spinal arthritis (axSpA) than in healthy individuals The study was designed to d
-
What is the diagnostic value of Clinica Chimica Acta: 14-3-3 thain and anti-carbide protein antibodies in northern Han rheumatoid arthritis?
Time of Update: 2020-05-29
Rheumatoid arthritis (RA) cannot be ruled out when rheumatoid factor (RF) or anticyclic gualine peptide antibody (anti-ccp) is negative Here, we identified the application value of 14-3-3 proteins,
-
Lilly announces clinical study to evaluate JAK inhibitors Olumiant and antiangitosin-2 mono-antilyialysis LY3127804 for treatment of new coronavirus COVID-19 patients
Time of Update: 2020-05-29
Lilly announced that it has reached an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) to begin testing Olumiant as a potential treatment for patients hospitalized
-
NICE UPDATES MANAGEMENT GUIDELINES FOR NEW CORONARY VIRAL INFECTIONS WITH UNDERLYING DISEASES
Time of Update: 2020-05-29
The National Institute for Health and Care Excellence (NICE) has published new guidelines for the management of patients with suspected and confirmed new coronavirus COVID-19 The new guidelines inc
-
1 case of combined D-dipolymer stubbornness in combination with primary dry ness syndrome
Time of Update: 2020-05-29
Primary dryness syndrome is a chronic progressive autoimmune disease that is multi-system affected, mainly due to the secretion glands The clinical incidence of the disease is hidden, clinical perf
-
Arthritis Rheumatol: Endoderic and inflammatory biomarker characteristics at diagnosis can predict the therapeutic response of juvenile dermatitis
Time of Update: 2020-05-29
Adolescent dermatitis ( JDM ) is a heterogeneous systemic immune mediated vascular disease, the objective of this study is: 1 ) to determine the inflammatory / endothelial dysfunction associa
-
J Rheumatol: Changes in attachment points due to age, body mass index and physical activity: ultrasound study of healthy populations
Time of Update: 2020-05-29
The purpose of this study was to investigate the prevalence of ultrasound (US) lesions and their influencing factors at health attachment sites scan scans of 960 attachment points in 80 healthy s
-
CD28/ICOS dual T-cell co-stimulation inhibitor ALPN-101 for the prevention and treatment of acute transplant anti-host disease, while winning the FDA's designation of two orphan drugs
Time of Update: 2020-05-29
Alpine Immune Sciences announced that the U.S Food and Drug Administration (FDA) has designated two orphan drugs for the use of its ALPN-101 (Selective Dual T-Cell Costimulation Factor Inhibitor) f
-
Ann Rheum Dis: Serum metabolism group and lipid group differences identified potential biomarkers of seronegative rheumatoid arthritis vs psoriasis arthritis
Time of Update: 2020-05-29
Due to similar symptoms and lack of reliable clinical markers, it is often difficult to identify seronegative rheumatoid arthritis ( negRA ) and psoriasis arthritis ( PsA ) to diagnose Since ch
-
J Rheumatol: Correlation between improved disease activity scores in patients with childhood dermatitis and validated original disease activity scores
Time of Update: 2020-05-29
Childhood dermatitis (JDM) is a rare disease that can be treated in children, but patients may be exposed to long-term effects of the disease Clinical trials are needed to find better treatments Th
-
Semin Arthritis Rheu: Endemic Osteopathic Disease: Bone Joint Disease from a Food Source
Time of Update: 2020-05-29
Osteopathic disease (KBD) is a endemic bone joint disease that can cause disability and a heavy socio-economic burden Precautions have been taken over the past few decades However, it is necessary
-
Arthritis Rheumatol: Recombinant adenosine deaminase improves inflammation, vascular disease and fibrosis in preclinical models of systemic sclerosis
Time of Update: 2020-05-29
Systemic sclerosis (SSc) is characterized by fibrosis, vascular disease and inflammation Adenosine signaling plays an important role in fibroblast activation The purpose of this study was to assess
-
Ann Rheum Dis: Bimekizumab Double Middle and Lemynesin-17A and 17F Therapeutic Aggressive Syllitis
Time of Update: 2020-05-29
Bimekizumab selective lymes (IL)-17A and IL-17F The efficacy and safety of bimekizumab in a phase IIb dose-range study of active syllable scoliosis (AS) are reported here randomly divided adult A
